臓器移植患者の感染制御 - jscm.org

CLSI A One Health Perspective on Susceptibility …

1 CLSI –A One Health Perspective on Susceptibility Testing Dr. Jeffrey L. Watts, PhD, RM (NRCM), M (ASCP) Director, External Innovation –Anti-Infectives Zoetis, Inc

  Health, Perspective, Testing, One health perspective on susceptibility, Susceptibility, One health perspective on susceptibility testing

CT - jscm.org

ct 6 ˘ˇ ˆ˙˝ ˘ ˛˚ ˜ ˘˚ ! "#$ %& ’( ) *˘ ˇ+,)- .ˆ’(˙/ ˇ˝ ˛ ˚˜ !" 01#234$5

Moraxella osloensis 1 - jscm.org

4 dna 16s rrna ˘ ˇˆ8ua (5 -agagtttgatcmtggctcag-3 ), 1485b (5 -taccgttaccttgttacgac-3 ) ˙ ˝˛˚˜ pcr ˘ pcr

  Moraxella osloensis, Moraxella, Osloensis

TRC TRCRapid M. TB - jscm.org

pcr n- -a- ˘(nalc) ˇ ˆ ˙84 ˝˛ 67 ˚˛˜ 8 ˚˛!"#$ % 3 ˚˛&’3 ˚˛ 2 ˚˛( )*1 ˚˝ +nalc ˇ ˆ˙,- .˘/01234 (pbs) ˝1,000 ml˛pcr ˙ 5 100 ml˛

  Nalc, Trc trcrapid m, Trcrapid

バンコマイシン耐性腸球菌 - jscm.org

10 日本臨床微生物学雑誌 Vol.24 No.3 2014. Ⓒ日本臨床微生物学会2014 [総 説] バンコマイシン耐性腸球菌 富田治芳 1）2）・野村隆浩・久留島潤・谷本弘一2） 1）群馬大学大学院医学系研究科細菌学分野 2）群馬大学大学院医学系研究科附属薬剤耐性菌実験施設 （平成26年7月31日受付）

  Smcj

coagulase-negative staphylococci

7) 2003. 4: 153 155. 8) Kirchho#,L.V., J. N. Sheagren. 1985. Epidemi-ology and clinical significance of blood cul-tures positive for coagulase-negative staphylo-

  Negative, Coagulase negative staphylococci, Coagulase, Staphylococci

Loop-mediated isothermal amplification（LAMP） …

LAMP法によるレジオネラ属菌の検出 6×106 CFU/mlおよび約6×108 CFU/mlに希釈し た。これらは95℃で5分間の熱処理後，氷冷して， 12,000 rpm，4℃，10分間の遠心分離を行 …

  Lamp

ƒ⁄‹ˇˆ˙ . 2007 53 - jscm.org

Acinetobacter ursingii Nemec et al. 2001 51: 1898 2 Actinobacillus capsula-tus Arseculeratne 1962 30: 241 1980 Class 2 2(t) Actinobacillus delphini-

  2007, Smcj, 2007 53 jscm

Fusobacterium necrophorum - jscm.org

ACase of Retropharyngeal Lymph Node Abscess Which Fusobacterium necrophorum Was Isolated from Blood Culture Keiko Kaiho,1) Naruhiko Ishiwada,1) Haruka Hishiki,1) Masaharu Watanabe,2) Yoichi Kohno1)

  Smcj, Fusobacterium necrophorum, Fusobacterium, Necrophorum

広域β-ラクタム薬耐性に関与するβ-ラクタマーゼの …

荒川宜親 14 日本臨床微生物学雑誌 Vol.13 No.3 2003. 152 までには至っていなかった。しかし，1990年には， プラスミド依存性にCAZに耐性を獲得したKlebsiella

First Report of AIDS

First Report of AIDS Twenty years ago, on June 5, 1981, MMWR published a report of five cases of Pneumocystis carinii pneumonia (PCP) among previously healthy young men in Los

  First, Report, Aids, First report of aids, Pneumocystis

Pneumocystis jiroveci Pneumonia: High-Resolution CT ...

AJR:198, June 2012 W557 CT of Pneumocystis jiroveci Pneumonia pneumonia between malignancy cases and ac-quired immunodeficiency syndrome cases: a mul - …

  Pneumocystis

Etiology and Clinical Outcome of Non-Resolving Pneumonia ...

© JAPI • febru Ary 2012 • VOL. 60 21 age group was 51-60 years. fever (80%) and cough (87.1%) were the most common symptoms.70% of patients had symptom

  Clinical, Outcome, Etiology, Resolving, Etiology and clinical outcome of non resolving

¿Cuándo sospechar de la inmunodeficiencia combinada grave ...

Artículo de revisión Vol. 23, Núm. 1 • Enero-Abril 2014 pp -.medigraphic.org.mx ¿Cuándo sospechar de la inmunodeficiencia combinada grave en niños?

Deprim - Medsafe

Deprim Sulfamethoxazole 200mg and Trimethoprim 40mg per 5mL Oral Suspension Presentation Deprim Suspension is a pink, raspberry flavoured suspension containing 200 mg

  Primed

HIGHLIGHTS OF PRESCRIBING INFORMATION pneumonia …

3 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Newly Diagnosed Glioblastoma Multiforme TEMODAR® (temozolomide) is indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment.

  Temodar